Фармакологическое действие и клиническое применение цитиколина: обзор экспериментальных данных и клинических исследований
- Авторы: Сергиенко М.Е1
-
Учреждения:
- Дорожная клиническая больница на ст. Челябинск ОАО РЖД
- Выпуск: Том 26, № 13 (2019)
- Страницы: 91-95
- Раздел: Статьи
- URL: https://journals.eco-vector.com/2073-4034/article/view/312396
- DOI: https://doi.org/10.18565/pharmateca.2019.13.91-95
- ID: 312396
Цитировать
Полный текст
![Открытый доступ](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_open.png)
![Доступ закрыт](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_unlock.png)
![Доступ закрыт](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Аннотация
Цитидин 5-дифосфохолин (ЦДФ-холин, или цитиколин) является незаменимым промежуточным веществом в биосинтезе структурных фосфолипидов в клеточных мембранах, в частности фосфатидилхолина. Обзор посвящен исследованиям препарата цитиколин. Освещены экспериментальные данные его влияния на травматическое повреждение и экспериментальный отек головного мозга, а также результаты клинического применения при черепно-мозговой травме и ее последствиях.
Полный текст
![Доступ закрыт](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Об авторах
М. Е Сергиенко
Дорожная клиническая больница на ст. Челябинск ОАО РЖД
Email: smarfor@mail.ru
врач-невролог, врач высшей квалификационной категории
Список литературы
- Grieb P. Neuroprotective properties of citicoline: facts, doubts and undersolved issues. CNS. Drugs. 2014;28:185-93. doi: 10.1007/s40263-014-0144-8.
- Martinez M., Conde C., Ballabriga A. Some chemical aspects of human brain development II Phosphoglictride fatty acids. Pediatr Res. 1974;9:93-U)2.
- Gonzalez-Padrones T., Rodriguez-Fernandez C. Los fosfolipidos como indice de maduracion cerebral. Rev Clin Esp. 1982;167:99-101.
- Padmini S., Srinivasa Rao P. UPDgalactos: ceramide galactosyltransferase, CDF choline in maijor regions of the developing rat brain in nutritional stress. Neurosci Res. 1989;23:310-15.
- Bramanti V., Bronzi D., Tomassoni D., et al. Effects of choline-containing phospholipids on transglutaminase activity in primary astroglial cell cultures. Clin Exp Hypertens. 2008;30:798-807. doi: 10.1080/10641960802563576.
- Paoletti L., Domizi P., Marcucci H., et al. Lisophosphatidilcholine drives neuroblast cell fate. Mol. Neurobiol. 2016;53(9):63 1 6-31. doi: 10.1007/s12035-015-9528-0.
- Lozano R. La membrane neuronal: implicaciones terapeuticas. Boletin de Neurol. 1993;2:3-8.
- McMurray W.C., Magee WL. Phospholipid metabolism. Ann Rev Biochem. 1972;41:129-61.
- Nilsson B. CDP-choline: a shot review. Drug treatment and prevention in cerebrovascular disorders. Amsterdam: Elsvier/North Holland Biomedical Press. 1979. P. 273-77.
- Agut J. Neurotransmissores y membrane neuronal. Rev Esp Geriatr Gerontol. 1989;24:16-21.
- Albergina M., Giuffrida-Stella A.M. Changes of phospholipidmetabolizing and lysosomal enzymes in hypoglossal nucleus and ventral horn motoneurons during regeneration of craniospinal nerves. J. Neurochem. 1988;51:15-20.
- Boismare F. Souffrance cerebraile: cjmportment et neurotransmetteurs sur des modeles experimentaux. 1980.
- Hayaishi O., Ozawa K., Araki C., et al. Biochemical studies of head injury and brain edema. Jpn J. Med Prog. 1961;48:519-39.
- Homayoun P., Parkins N.E., Soblosky J., et al. Cortical impact injury in rats promoters a rapid and sustained increase in polyunsaturated free fatty acids and diacylgiycerols. Neurochem Res. 2000;25:269-76.
- De la Morena E., Goldberg D.M., Werner M. Citidindifosfato de cjlina y biosintes de fosfolipidos. Barselona: Salvat, 1985. P. 25-38.
- Vance D.E., Pelech S.L. Cellular translocation of CTP:phosphocholine cytydyltransferase regulates the synthesis of CDPcholine. Amsterdam: Elsevier Science Publishing, 1985. P. 15-24.
- Tayebati S.K., Amenta F. Choline-containing phospholipids: relevance to brain functional pathways. Clin Chem Lab Med. 2013;51:513-21. doi: 10.1515/cclm-2012-0559.
- Ogasiwa M., Takeuchi K., Hara M., et al. Studies on the intrathecal pharmacotherapy. Part I: CDPcholine. Int J. Clin Pharmacol. 1975;12:327-35.
- Watanabe S., Kono S., Nakashima Y., et al. Effects of varios cerebral metabolic activators on glucose metabolism of brain. Folia Psychiat Neurol Jpn. 1975;29:67-76.
- Arrigoni E., Averet N., Cohadon F. Effects of CDP-choline on phospholipase A2 and cholinephosphotransferase activities following a cryogenic brain injury in the rabbit. Biochem Pharmacjl. 1987;36:3697-700.
- Freysz L., Golly F., Mykita S., et al. Metabolism of neuronal cell culture: Modifications induced by CDP-choline. Novel biochemical, pharmacological and clinical aspects CDP-choline Amsterdam: Elsevier Science Publishing, 1985. P. 117-25.
- Algate D.R., Beard D.J., Sacristan A., et al. Study on the effects of oral administration CDP-choline on EEG changes and lethality induced by epidural compression in the anesthetized cat. Arzneimittelforschung. 1983;33(2):1013-16.
- Hayaishi O., Ozawa K., Araki C., et al. Biochemical studies of head injury and brain edema. Jpn J. Med Prog. 1961;48:519-39.
- Kondo Y. Experimental study of the therapeutic use of cytidine nucleotids for brain injury. Nihon Geka Hokan. 1964;32:489-505.
- Boismare F., LePoncin M., et al. Etude des effets de la administration de cytidinediphosphocholine sur les consequences hemodynamiques, fonctionelles, et biochimiques du traumatisme cranioctrvical chez le rat. Therapie. 1977;32:345-54.
- Dixon C.E., Ma X., Marion D.W. Effects of CDP-choline treatment on neurobehavioral deficits after TBI and on hippocampal and neocortical acetylcholine release. J. Neurotrauma. 1997;19:161-69.
- Baskaya M.K., Dogan A., Rao A.M., et al. Neuroprotective effects of citicoline on brain edema and blood-brain barrier breakdown after traumatic brain injury. J. Neurosurg. 2000;92:448-52.
- Cakir E., Usul H., Peksoylu B., et al. Effects of citicoline on experimental spinal cord injury. J. Clin Neurosci. 2005;12:924-27.
- Wang L., Rouleau D.M., Beamont E. Most effective adjuvant tretments after surgery in peripheral nerve laceration: systematic review of the literature on rodent models. Restor Neurol Neurosci. 2013;31:253-62. doi: 10.3233/RNN-120253.
- Levin H.S. Treatment of postconcussional symptoms with CDP-choline. J. Neurol Sci. 1991;103:39-42.
- Anniruddha T.J., Pillai S., Devi B.I., et al. Role of citicoline in the management of mild head injury. Indian J. Neurotrauma. 2009;6:49-52. doi: 10.1080/02699050802132495.
- Leon-Carrion J., Dominguez-Roldan J.M., Murillo-Cabezas F., et al. Advances in the treatment of memory deficits after citicholine. 3rd World Congress on Brain Injury. Quebec, 1999.
- Leon-Carrion J., Dominguez-Roldan J.M., Murillo-Cabezas F., et al. Normalization of memory-related cerebral blood flow in severe traumatic brain injury patients and improvements of memory induced by citicholine (CDP-choline): the role of a pro-cogntive drug. ICRAN 99. Taiwan, 1999.
- Leon-Carrion J., Dominguez-Roldan J.M., Murillo-Cabezas F., et al. The role of citicholine in neuropsycholjgical training after traumatic brain injury. Neurorehabilitation. 2000;14:33-40.
- Wortzel H.S., Arciniegas D.B. Treatment of post-traumatic cognitive impairments. Curr Treat Options Neurol. 2012;14:493-508. doi: 10.1007/s11940-012-0193-6.
- Spiers PA., Hochanadel G. Citicoline for traumatic brain injury: report of two cases, including my own. J. Int. Neuropsychol Soc. 1999;5:260-64.
- Chinnock P., Pokkunuri V. CDP-choline for acute traumatic brain injury. Cochrane Database Syst Rev. 2005;3:CD005402.
- Zafonte R., Friedewald W.T., Lee S.M., et al. The citicoline brain injury treatment (COBRIT) trial: design and methods. J. Neurotrauma. 2009;26:2207-16. Doi: 10.1089/ neu.2009.1015.
- Zafonte R.D., Bagiella E., Ansel B.M., et al. Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT). JAMA. 2012;308:1993-2000. Doi: 10.1001/ jama.2012.13256.
- Secades J.J. Citicoline for the treatment of head injury: a systematic review and meta-analysis of controlled clinical trials. J. Trauma Treat. 2014;4:227.
- Sayed I., Zaki A., Fayed A.M., et al. A metaanalysis of the different neuroprotective drugs in management of patients with traumatic brain injury. Neurosurg Rev. 2018;41(2):427-38. doi: 10.1007/s10143-016-0775-y.
- El Reweny E.M., Okasha A., Hafez A. The neuroprotective effect of citicholine (CDP choline) in patients with traumatic brain injury, 25th ESICM Annual Congress, Lisbon, Portugal, 2012.
- Salehpour F., Shokouhi G., Shakeri M., et al. Neuroprotective effects of citicoline in diffuse axonal injuries. Adv Biosci Clin Med. 2013;1:12-5.
Дополнительные файлы
![](/img/style/loading.gif)